tiprankstipranks
Trending News
More News >
Captor Therapeutics SA (DE:60Q)
STUTTGART:60Q
Germany Market
Advertisement

Captor Therapeutics SA (60Q) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

60Q Financial Forecast

60Q Earnings Forecast

The previous quarter’s earnings for 60Q were -€0.41.
The previous quarter’s earnings for 60Q were -€0.41.

60Q Sales Forecast

The previous quarter’s earnings for 60Q were €471.46K.
The previous quarter’s earnings for 60Q were €471.46K.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on DE:60Q
TR | OpenAI - 4o
TR | OpenAI - 4o
€8.2
Sell
-2.58%
Downside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on DE:60Q
TR | OpenAI - 4o
TR | OpenAI - 4o
€8.2
Sell
-2.58%
Downside
Initiated
09/14/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Captor Therapeutics SA

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.20%
initiated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -0.20% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.20%
initiated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.20% per trade.
1 Year
Dex GenotekTR | OpenAI - 4o
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.20%
initiated a sell rating 17 days ago
Copying Dex Genotek's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.20% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-0.20%
initiated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -0.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

60Q Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

60Q Stock Forecast FAQ

What is DE:60Q’s average 12-month price target, according to analysts?
Based on analyst ratings, Captor Therapeutics SA’s 12-month average price target is 8.67.
    What is DE:60Q’s upside potential, based on the analysts’ average price target?
    Captor Therapeutics SA has 2.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Captor Therapeutics SA a Buy, Sell or Hold?
          Captor Therapeutics SA has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Captor Therapeutics SA’s share price target?
            The average share price target for Captor Therapeutics SA is 8.67. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €8.67 ,and the lowest forecast is €8.67. The average share price target represents 2.97% Increase from the current price of €8.42.
              What do analysts say about Captor Therapeutics SA?
              Captor Therapeutics SA’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Captor Therapeutics SA?
                To buy shares of DE:60Q, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis